All Relations between somatostatin and insulin

Publication Sentence Publish Date Extraction Date Species
M Berger, C Bordi, H J Cüppers, P Berchtold, F A Gries, H Münterfering, R Sailer, H Zimmermann, L Orc. Functional and morphologic characterization of human insulinomas. Diabetes. vol 32. issue 10. 1983-11-23. PMID:6311653. based on these findings, we propose a new classification of insulinomas in two groups: group a is characterized morphologically by abundant well-granulated typical b-cells, trabecular arrangement of tumor cells, and uniform insulin immunofluorescence; functionally, these tumors are associated with a moderate elevation of proinsulin-like component and with an almost complete suppressibility of serum insulin by somatostatin and diazoxide. 1983-11-23 2023-08-12 human
M Berger, C Bordi, H J Cüppers, P Berchtold, F A Gries, H Münterfering, R Sailer, H Zimmermann, L Orc. Functional and morphologic characterization of human insulinomas. Diabetes. vol 32. issue 10. 1983-11-23. PMID:6311653. in contrast, tumors of group b are characterized by scarce well-granulated typical b-cells, a medullary-type histologic structure, and irregular insulin immunofluorescence; functionally these tumors show elevated circulating levels of proinsulin-like component and a marked resistance of insulin secretion to somatostatin and diazoxide inhibition. 1983-11-23 2023-08-12 human
K Kawa. [Regulation mechanism of insulin and glucagon secretion from the isolated, perfused canine pancreas by somatostatin]. Horumon to rinsho. Clinical endocrinology. vol 31. issue 5. 1983-10-28. PMID:6136354. [regulation mechanism of insulin and glucagon secretion from the isolated, perfused canine pancreas by somatostatin]. 1983-10-28 2023-08-12 Not clear
G Dimitriadis, P Tessari, J Geric. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus. Metabolism: clinical and experimental. vol 32. issue 10. 1983-10-28. PMID:6136893. to determine whether an agent such as wy-41,747, a long-acting somatostatin analogue, could be useful as an adjunct to insulin in the treatment of diabetes mellitus, postprandial plasma glucose concentrations were determined in subjects with insulin-dependent diabetes rendered euglycemic with the biostator insulin infusion device under four conditions: (1) subcutaneous minipump infusion of insulin alone (13 +/- 1 units) over 30 minutes beginning 30 minutes before ingestion of a meal using insulin doses determined by the biostator; (2) the same conditions as 1 but beginning immediately before meal ingestion; (3) the same conditions as 1 but with less insulin (7 +/- 1 units) accompanied by the analogue (0.01-0.05 mg/kg); (4) the same conditions as 2 but with the analogue and less insulin (11 +/- 1 units). 1983-10-28 2023-08-12 human
G Dimitriadis, P Tessari, J Geric. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus. Metabolism: clinical and experimental. vol 32. issue 10. 1983-10-28. PMID:6136893. administration of the somatostatin analogue increased the effectiveness of insulin in controlling postprandial hyperglycemia and permitted satisfactory postprandial glycemic control when the insulin infusion was initiated immediately before meal ingestion. 1983-10-28 2023-08-12 human
G Dimitriadis, P Tessari, J Geric. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus. Metabolism: clinical and experimental. vol 32. issue 10. 1983-10-28. PMID:6136893. these results suggest that subcutaneous administration of a long-acting somatostatin analogue such as wy-41,747 along with insulin may be clinically useful in the treatment of diabetes mellitus. 1983-10-28 2023-08-12 human
C G Ostenso. Effects of the biguanide synthalin A on the pancreatic A2-cell of the guinea pig. Experimental and clinical endocrinology. vol 81. issue 3. 1983-10-28. PMID:6350026. the enhanced glucagon release by 5 micrograms/ml of the drug was not suppressed by high concentrations of glucose plus insulin in the medium, whereas exogenous somatostatin markedly counter-acted glucagon release evoked by synthalin a. 1983-10-28 2023-08-12 Not clear
M El-Salhy, S Falkmer, K J Kramer, R D Speir. Immunohistochemical investigations of neuropeptides in the brain, corpora cardiaca, and corpora allata of an adult lepidopteran insect, Manduca sexta (L). Cell and tissue research. vol 232. issue 2. 1983-10-21. PMID:6136331. the neurosecretory cells found in the brain were immunoreactive with at least one of the following mammalian antisera, namely those raised against the insulin b-chain, somatostatin, glucagon c-terminal, glucagon n-terminal, pancreatic polypeptide (pp), secretin, vasoactive intestinal polypeptide (vip), glucose-dependent insulinotropic peptide (gip), gastrin c-terminus, enkephalin, alpha- and beta-endorphin, substance p, and calcitonin. 1983-10-21 2023-08-12 Not clear
V N Titov, R G Kazimov, L V Kasatkina, V P Masenko, S A Beznosenk. [Relations between insulin, somatotropic hormone and somatostatin secretions in patients with ischemic heart disease]. Kardiologiia. vol 23. issue 6. 1983-10-08. PMID:6136624. [relations between insulin, somatotropic hormone and somatostatin secretions in patients with ischemic heart disease]. 1983-10-08 2023-08-12 Not clear
V N Titov, R G Kazimov, L V Kasatkina, V P Masenko, S A Beznosenk. [Relations between insulin, somatotropic hormone and somatostatin secretions in patients with ischemic heart disease]. Kardiologiia. vol 23. issue 6. 1983-10-08. PMID:6136624. secretions of hormones responsible for carbohydrate metabolism, sth, insulin, s-peptide and somatostatin, were measured in coronary patients in order to investigate hormonal mechanisms involved in disordered carbohydrate metabolism. 1983-10-08 2023-08-12 Not clear
S Ito, S Isemura, E Saitoh, K Sanada, T Suzuki, A Shibat. Immunohistochemical demonstration of salivary proline rich peptide P-C like immunoreactivity in human pancreatic B-cells. Acta endocrinologica. vol 103. issue 4. 1983-10-08. PMID:6351525. as the antisera against peptide p-c did not have any cross-reactivities to insulin, glucagon, somatostatin, pancreatic polypeptide, vip and human c-peptide, the antisera were considered to recognize specifically either peptide p-c related antigen or peptide p-c itself in human pancreatic b-cells. 1983-10-08 2023-08-12 human
K Hermanse. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Endocrinology. vol 113. issue 3. 1983-09-23. PMID:6135603. enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. 1983-09-23 2023-08-12 dog
K Hermanse. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Endocrinology. vol 113. issue 3. 1983-09-23. PMID:6135603. it was found that mek (1-100 nm) dose dependently inhibited somatostatin release and stimulated insulin secretion. 1983-09-23 2023-08-12 dog
K Hermanse. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Endocrinology. vol 113. issue 3. 1983-09-23. PMID:6135603. ten micromolar of morphine inhibited somatostatin and stimulated insulin secretion, effects being antagonized by nal (10 microm). 1983-09-23 2023-08-12 dog
K Hermanse. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Endocrinology. vol 113. issue 3. 1983-09-23. PMID:6135603. nal (10 microm) per se did not affect somatostatin or insulin secretion at 8.3 mm glucose. 1983-09-23 2023-08-12 dog
K Hermanse. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Endocrinology. vol 113. issue 3. 1983-09-23. PMID:6135603. infusions of either 1 microm phentolamine, 1 microm propranolol, or 1 microm atropine did not significantly alter the amount of somatostatin or insulin secretion during the infusion of 50 nm mek. 1983-09-23 2023-08-12 dog
I C Green, D Perrin, E Penman, A Yaseen, K Ray, S L Howel. Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans. Diabetes. vol 32. issue 8. 1983-09-20. PMID:6135634. effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-amp levels in isolated rat islets of langerhans. 1983-09-20 2023-08-12 rat
I C Green, D Perrin, E Penman, A Yaseen, K Ray, S L Howel. Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans. Diabetes. vol 32. issue 8. 1983-09-20. PMID:6135634. dynorphin had no effect on islet somatostatin secretion, under conditions in which insulin secretion was greatly stimulated. 1983-09-20 2023-08-12 rat
I C Green, D Perrin, E Penman, A Yaseen, K Ray, S L Howel. Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans. Diabetes. vol 32. issue 8. 1983-09-20. PMID:6135634. glucose (20 mm) and glyceraldehyde (6 and 12 mm) significantly increased both insulin and somatostatin secretion. 1983-09-20 2023-08-12 rat
I C Green, D Perrin, E Penman, A Yaseen, K Ray, S L Howel. Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans. Diabetes. vol 32. issue 8. 1983-09-20. PMID:6135634. these results suggest that (1) dynorphin is a very potent stimulus for insulin secretion; (2) dynorphin does not affect somatostatin secretion in static incubations of islets, in the same way as does glucose and glyceraldehyde; (3) dynorphin's effects may involve increased calcium ion movement and can be blocked by verapamil; (4) dynorphin can also increase islet c-amp, and could thereby modulate the responsiveness of other secretagogues; (5) the actions of dynorphin on insulin secretion are not mediated by delta or mu opiate receptors in islets. 1983-09-20 2023-08-12 rat